Trying to shed light on the solution to this emerging conundrum, we will review in detail the clinical, pathological, and molecular data of TFE3-rearranged renal cell carcinomas and TFE3-rearranged renal PEComa. This evidence concerns the gene TFE3 and renal cell carcinoma.